BioSpace News Archive

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the third quarter ended September 30, 2021.

Submission of NDA for Omecamtiv Mecarbil on Track to Occur in Q4 2021 Start-Up Activities Underway for SEQUOIA-HCM Enrollment Complete in Cohort 3 of REDWOOD-HCM; Results Expected in Q1 2022

Conformis, Inc. announced today financial results for the third quarter ended September 30, 2021.

InspireMD, Inc. announced that results from the investigator-initiated SIBERIA randomized clinical trial of CGuard EPS, that evaluated the peri-procedural and 30-day silent brain infarcts associated with the use of its MicroNet™ covered stent versus a conventional “workhorse” open-cell Acculink™ nitinol stent were published this week.

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer of novel biotherapeutics, and Nestlé Health Science, a globally recognized leader in the field of nutritional science, announced today the dosing of the first subject in a Phase 1 study to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of CDX-7108.

Supernus Pharmaceuticals today reported financial results for the third quarter of 2021, and associated Company developments.

Summit Therapeutics Inc. today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors, effective immediately.

Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing, today announced the initial results 1 from the global, multi-site, prospective Trifecta study

Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, announces the successful collaboration with Exact Sciences, a global leader in cancer diagnostics, to advance early cancer detection.

Sensei Biotherapeutics, Inc. today announced that John Celebi, president and chief executive officer, will participate in a fireside chat at the Berenberg virtual U.S. CEO Conference on Tuesday, November 9 at 10:00 a.m. EST.